FI883487A0 - Ihmisen kudostekijäinhibiittorin DNA-klooni - Google Patents

Ihmisen kudostekijäinhibiittorin DNA-klooni

Info

Publication number
FI883487A0
FI883487A0 FI883487A FI883487A FI883487A0 FI 883487 A0 FI883487 A0 FI 883487A0 FI 883487 A FI883487 A FI 883487A FI 883487 A FI883487 A FI 883487A FI 883487 A0 FI883487 A0 FI 883487A0
Authority
FI
Finland
Prior art keywords
human tissue
tissue factor
factor inhibitor
dna clone
tfi
Prior art date
Application number
FI883487A
Other languages
English (en)
Swedish (sv)
Other versions
FI93365C (fi
FI93365B (fi
FI883487A (fi
Inventor
Jr George John Broze
Kuniko Kusano Kretzmer
Tze-Chein Wun
Original Assignee
Monsanto Co
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22410671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI883487(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/123,753 external-priority patent/US4966852A/en
Application filed by Monsanto Co, Univ Washington filed Critical Monsanto Co
Publication of FI883487A0 publication Critical patent/FI883487A0/fi
Publication of FI883487A publication Critical patent/FI883487A/fi
Application granted granted Critical
Publication of FI93365B publication Critical patent/FI93365B/fi
Publication of FI93365C publication Critical patent/FI93365C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI883487A 1987-11-23 1988-07-22 Ihmisen kudostekijäinhibiittorin DNA-klooni FI93365C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/123,753 US4966852A (en) 1987-07-23 1987-11-23 DNA clone of human tissue factor inhibitor
US12375387 1987-11-23

Publications (4)

Publication Number Publication Date
FI883487A0 true FI883487A0 (fi) 1988-07-22
FI883487A FI883487A (fi) 1989-05-24
FI93365B FI93365B (fi) 1994-12-15
FI93365C FI93365C (fi) 1995-03-27

Family

ID=22410671

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883487A FI93365C (fi) 1987-11-23 1988-07-22 Ihmisen kudostekijäinhibiittorin DNA-klooni

Country Status (15)

Country Link
EP (1) EP0318451B1 (fi)
JP (5) JP2836823B2 (fi)
KR (1) KR930000274B1 (fi)
AT (1) ATE111518T1 (fi)
AU (1) AU604139B2 (fi)
CA (1) CA1341223C (fi)
DE (1) DE3851511T2 (fi)
DK (1) DK173536B1 (fi)
ES (1) ES2063769T3 (fi)
FI (1) FI93365C (fi)
IE (1) IE65393B1 (fi)
IL (1) IL87171A (fi)
NO (2) NO310466B1 (fi)
NZ (1) NZ225535A (fi)
PT (1) PT88076B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner
US5378614A (en) * 1989-08-18 1995-01-03 Novo Nordisk A/S Vector and method for making tissue factor pathway inhibitor (TFPI) analogues in yeast
EP0439442B1 (en) * 1990-01-25 1996-03-06 Washington University Factor x-laci hybrid protein
IE913004A1 (en) * 1990-08-27 1992-03-11 Monsanto Co Anticoagulant combination of laci and sulfated¹polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5346991A (en) * 1991-06-13 1994-09-13 Genentech, Inc. Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US5455338A (en) * 1993-11-05 1995-10-03 Zymogenetics, Inc. DNA encoding novel human kunitz-type inhibitors and methods relating thereto
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
AU2002365131B2 (en) 2001-10-15 2007-03-01 Novartis Vaccines And Diagnostics, Inc. Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI)
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
SI1981519T1 (en) 2005-12-29 2018-05-31 Dyax Corp. INHIBITION PROTEAZE
DK2379096T3 (da) 2008-12-19 2019-11-25 Baxalta GmbH TFPI-inhibitorer og fremgangsmåder til anvendelse
US8450275B2 (en) 2010-03-19 2013-05-28 Baxter International Inc. TFPI inhibitors and methods of use
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
JP6037841B2 (ja) 2010-01-06 2016-12-07 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
RU2013158627A (ru) * 2011-06-15 2015-07-20 Ф. Хоффманн-Ля Рош Аг Антитела к рецептору человеческого эритропоэтина и способы их применения
HUE046572T2 (hu) 2012-03-21 2020-03-30 Baxalta GmbH TFPI inhibitorok és alkalmazási eljárások
CN108602893A (zh) 2015-12-11 2018-09-28 戴埃克斯有限公司 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
IL87172A (en) * 1987-07-23 1994-12-29 Univ Washington A method of inhibiting the isolation of a purer tissue factor

Also Published As

Publication number Publication date
AU604139B2 (en) 1990-12-06
DE3851511D1 (de) 1994-10-20
NO883270L (no) 1989-05-24
FI93365C (fi) 1995-03-27
JP2002097200A (ja) 2002-04-02
JP2005306875A (ja) 2005-11-04
JPH1175875A (ja) 1999-03-23
PT88076A (pt) 1988-08-01
DK413488A (da) 1989-05-24
DK173536B1 (da) 2001-02-05
EP0318451A2 (en) 1989-05-31
EP0318451B1 (en) 1994-09-14
JP2004201696A (ja) 2004-07-22
ATE111518T1 (de) 1994-09-15
FI93365B (fi) 1994-12-15
JP2836823B2 (ja) 1998-12-14
EP0318451A3 (en) 1990-03-28
DK413488D0 (da) 1988-07-22
FI883487A (fi) 1989-05-24
JP4025035B2 (ja) 2007-12-19
NO310466B1 (no) 2001-07-09
IL87171A0 (en) 1988-12-30
IE882243L (en) 1989-05-23
KR890007750A (ko) 1989-07-05
JP3565714B2 (ja) 2004-09-15
IL87171A (en) 1995-08-31
DE3851511T2 (de) 1995-03-30
JPH01165383A (ja) 1989-06-29
NO20013608L (no) 1989-05-24
PT88076B (pt) 1993-01-29
IE65393B1 (en) 1995-10-18
AU1928788A (en) 1989-05-25
ES2063769T3 (es) 1995-01-16
NO883270D0 (no) 1988-07-22
CA1341223C (en) 2001-05-01
NZ225535A (en) 1990-11-27
NO20013608D0 (no) 2001-07-20
KR930000274B1 (ko) 1993-01-14

Similar Documents

Publication Publication Date Title
NO883270L (no) Dna-klon for human vevfaktorinhibitor.
ATE142258T1 (de) Menschlicher gefässpermeabilitätsfaktor
GB2213381B (en) Surgical diathermy instruments
BR8707937A (pt) Protese para osteosintese
DK450887A (da) Kirurgisk klammepistol
AR227252A1 (es) Procedimiento para la fabricacion de un aglutinante para tejidos a base de proteinas humanas o animales
BR8807112A (pt) Forceps cirurgico
BR1100464A (pt) Inibidor de fator tecidual humano
ATE140962T1 (de) Dns-klone von menschlichem thrombomodulin
ZA898553B (en) The use of ethylenediaminetetraacetic acid as inhibitor of calcium/calmodulin-dependent protein kinase ii or of protein kinase c
IT8448082A0 (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione
IT8719433A0 (it) Procedimento per la preparazione di alfafetoproteina umana.
IT1212555B (it) Composizione a base di dobesilato di calcio per il trattamento di malattie cardiache
NO914588D0 (no) Enzymkatalysert fremgangsmaate for fremstilling av n-acyl-aminosyrer og n-acyl-aminosyreamider
IE860985L (en) Human anti-inflammatory phospholipase inhibitor protein
IT8867135A0 (it) Protesi ad espansione endoluminale particolarmente per il trattamentodi patologie vascolari
IT8547715A0 (it) Apparecchio e procedimento per la fabbricazione di protesi dentarie
SE8605216L (sv) Ny medicinsk anvendning
KR870000729U (ko) 양말 토우부용 봉합기
DK435889D0 (da) Delimbing of blood specially for human

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: WASHINGTON UNIVERSITY

Owner name: MONSANTO COMPANY